* . *
  • About
  • Advertise
  • Privacy & Policy
  • Contact
Monday, June 30, 2025
Earth-News
  • Home
  • Business
  • Entertainment
    Susquehanna Raises Penn Entertainment Inc. (PENN) Price Target. – Yahoo Finance

    Susquehanna Raises Price Target for Penn Entertainment Inc. (PENN)

    George Lopez is coming to Spokane – KXLY.com

    George Lopez is coming to Spokane – KXLY.com

    Netflix unveils Dallas immersive venue for fans of hit shows like ‘Squid Game,’ ‘Stranger Things’ – Houston Chronicle

    Step Inside Netflix’s New Dallas Immersive Experience Featuring Hits Like ‘Squid Game’ and ‘Stranger Things

    ‘Puttin’ on the Ritz’: Civic Players bring ‘Young Frankenstein’ to life – Yahoo

    Civic Players Deliver a Hilarious and Unforgettable Performance of ‘Young Frankenstein

    ‘Wheel of Fortune’: Amputee Wins $60,000 After Breaking Incredible ‘Curse’ – Hastings Tribune

    Wheel of Fortune’ Amputee Breaks Incredible ‘Curse’ to Win $60,000!

    North Star Sports & Entertainment Network: Coming soon – KTTC News

    North Star Sports & Entertainment Network: Coming soon – KTTC News

  • General
  • Health
  • News

    Cracking the Code: Why China’s Economic Challenges Aren’t Shaking Markets, Unlike America’s” – Bloomberg

    Trump’s Narrow Window to Spread the Truth About Harris

    Trump’s Narrow Window to Spread the Truth About Harris

    Israel-Gaza war live updates: Hamas leader Ismail Haniyeh assassinated in Iran, group says

    Israel-Gaza war live updates: Hamas leader Ismail Haniyeh assassinated in Iran, group says

    PAP Boss to Niger Delta Youths, Stay Away from the Protest

    PAP Boss to Niger Delta Youths, Stay Away from the Protest

    Court Restricts Protests In Lagos To Freedom, Peace Park

    Court Restricts Protests In Lagos To Freedom, Peace Park

    Fans React to Jazz Jennings’ Inspiring Weight Loss Journey

    Fans React to Jazz Jennings’ Inspiring Weight Loss Journey

    Trending Tags

    • Trump Inauguration
    • United Stated
    • White House
    • Market Stories
    • Election Results
  • Science
  • Sports
  • Technology
    New center coming to Mizzou will focus on energy research and technology – Columbia Missourian

    Mizzou Launches Innovative New Center Dedicated to Energy Research and Technology

    Mirrors in space and underwater curtains: can technology buy us enough time to save the Arctic ice caps? – The Guardian

    Can Technology Like Space Mirrors and Underwater Curtains Buy Us Time to Save the Arctic Ice Caps?

    Naples restaurant owner prepares for hurricane season with new flood technology – Fox4Now.com

    Naples restaurant owner prepares for hurricane season with new flood technology – Fox4Now.com

    Emerging Memory and Storage Technology Market Analysis Report 2025-2034 | AI and HPC Boom Fuels Surging Demand for Fast, Low-Power Memory Devices – Yahoo Finance

    How AI and HPC Are Driving Explosive Growth in Fast, Low-Power Memory Technologies Through 2034

    Ostin Technology (OST): Volatility’s Warning or Contrarian Opportunity? – AInvest

    Ostin Technology (OST): Navigating Market Volatility – Red Flag or Hidden Opportunity?

    St. Francis Medical Center brings advanced robotic surgery technology to Northeast Louisiana – KNOE

    St. Francis Medical Center brings advanced robotic surgery technology to Northeast Louisiana – KNOE

    Trending Tags

    • Nintendo Switch
    • CES 2017
    • Playstation 4 Pro
    • Mark Zuckerberg
No Result
View All Result
  • Home
  • Business
  • Entertainment
    Susquehanna Raises Penn Entertainment Inc. (PENN) Price Target. – Yahoo Finance

    Susquehanna Raises Price Target for Penn Entertainment Inc. (PENN)

    George Lopez is coming to Spokane – KXLY.com

    George Lopez is coming to Spokane – KXLY.com

    Netflix unveils Dallas immersive venue for fans of hit shows like ‘Squid Game,’ ‘Stranger Things’ – Houston Chronicle

    Step Inside Netflix’s New Dallas Immersive Experience Featuring Hits Like ‘Squid Game’ and ‘Stranger Things

    ‘Puttin’ on the Ritz’: Civic Players bring ‘Young Frankenstein’ to life – Yahoo

    Civic Players Deliver a Hilarious and Unforgettable Performance of ‘Young Frankenstein

    ‘Wheel of Fortune’: Amputee Wins $60,000 After Breaking Incredible ‘Curse’ – Hastings Tribune

    Wheel of Fortune’ Amputee Breaks Incredible ‘Curse’ to Win $60,000!

    North Star Sports & Entertainment Network: Coming soon – KTTC News

    North Star Sports & Entertainment Network: Coming soon – KTTC News

  • General
  • Health
  • News

    Cracking the Code: Why China’s Economic Challenges Aren’t Shaking Markets, Unlike America’s” – Bloomberg

    Trump’s Narrow Window to Spread the Truth About Harris

    Trump’s Narrow Window to Spread the Truth About Harris

    Israel-Gaza war live updates: Hamas leader Ismail Haniyeh assassinated in Iran, group says

    Israel-Gaza war live updates: Hamas leader Ismail Haniyeh assassinated in Iran, group says

    PAP Boss to Niger Delta Youths, Stay Away from the Protest

    PAP Boss to Niger Delta Youths, Stay Away from the Protest

    Court Restricts Protests In Lagos To Freedom, Peace Park

    Court Restricts Protests In Lagos To Freedom, Peace Park

    Fans React to Jazz Jennings’ Inspiring Weight Loss Journey

    Fans React to Jazz Jennings’ Inspiring Weight Loss Journey

    Trending Tags

    • Trump Inauguration
    • United Stated
    • White House
    • Market Stories
    • Election Results
  • Science
  • Sports
  • Technology
    New center coming to Mizzou will focus on energy research and technology – Columbia Missourian

    Mizzou Launches Innovative New Center Dedicated to Energy Research and Technology

    Mirrors in space and underwater curtains: can technology buy us enough time to save the Arctic ice caps? – The Guardian

    Can Technology Like Space Mirrors and Underwater Curtains Buy Us Time to Save the Arctic Ice Caps?

    Naples restaurant owner prepares for hurricane season with new flood technology – Fox4Now.com

    Naples restaurant owner prepares for hurricane season with new flood technology – Fox4Now.com

    Emerging Memory and Storage Technology Market Analysis Report 2025-2034 | AI and HPC Boom Fuels Surging Demand for Fast, Low-Power Memory Devices – Yahoo Finance

    How AI and HPC Are Driving Explosive Growth in Fast, Low-Power Memory Technologies Through 2034

    Ostin Technology (OST): Volatility’s Warning or Contrarian Opportunity? – AInvest

    Ostin Technology (OST): Navigating Market Volatility – Red Flag or Hidden Opportunity?

    St. Francis Medical Center brings advanced robotic surgery technology to Northeast Louisiana – KNOE

    St. Francis Medical Center brings advanced robotic surgery technology to Northeast Louisiana – KNOE

    Trending Tags

    • Nintendo Switch
    • CES 2017
    • Playstation 4 Pro
    • Mark Zuckerberg
No Result
View All Result
Earth-News
No Result
View All Result
Home Health

EMA Panel Nods to Seven New Cancer Drugs

June 1, 2024
in Health
EMA Panel Nods to Seven New Cancer Drugs
Share on FacebookShare on Twitter

At its May 30 meeting, the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) endorsed the approval of several cancer therapies. 

Cejemly

The drug review panel recommended granting marketing authorization for Cejemly (sugemalimab, SFL Pharmaceuticals Deutschland GmbH), intended for the first-line treatment of metastatic non–small cell lung cancer (NSCLC) in combination with platinum-based chemotherapy.

Lung cancer continues to be the leading cause of cancer-related deaths in Europe, resulting in a significant number of fatalities. Around 80% of all lung cancers are NSCLC, and about 55%-70% of patients with NSCLC are diagnosed with metastatic disease at the time of presentation.

Cejemly is a fully human, anti–programmed death–ligand 1 (PD-L1) immunoglobulin (Ig)–G4 monoclonal antibody. It is indicated for the first ‑ line treatment of adults with metastatic NSCLC with no sensitizing EGFR mutations, or ALK, ROS1, or RET genomic tumor aberrations.

The CHMP recommendation is based on positive results from the GEMSTONE-302 trial, which demonstrated significant and clinically meaningful progression-free survival and overall survival improvement with Cejemly plus chemotherapy compared with placebo plus chemotherapy in patients with previously untreated squamous and nonsquamous metastatic NSCLC.

The most common side effects of Cejemly include anemia (77.5%) and increase in aspartate aminotransferase (34.0%) and alanine aminotransferase (32.0%) levels.

Cejemly will be available as a 600-mg concentrate for solution for infusion. Its active substance is sugemalimab, an antineoplastic monoclonal antibody that potentiates T-cell responses, including antitumor responses, by blocking programmed cell death protein 1 binding to PD-L1 ligands.

Avzivi 

Avzivi, a bevacizumab biosimilar, received a positive opinion for the treatment of carcinoma of the colon or rectum; breast cancer; NSCLC; renal cell cancer; epithelial ovarian, fallopian tube, or primary peritoneal cancer; and carcinoma of the cervix.

Avzivi is highly similar to the reference product Avastin, which was authorized in the European Union in 2005. It has comparable efficacy, safety and immunogenicity to Avastin, as demonstrated in a phase 3 comparative study. 

Its approved indications are for:

Metastatic carcinoma of the colon or rectum in combination with fluoropyrimidine-based chemotherapy for the treatment of adults.Metastatic breast cancer:In combination with paclitaxel for first-line treatmentIn combination with capecitabine for first-line treatment in patients for whom other chemotherapy options, including taxanes or anthracyclines, are not appropriate. Patients treated with taxane and anthracycline-containing regimens in the adjuvant setting within the last 12 months should be excludedNSCLC:In combination with platinum-based chemotherapy for first-line treatment of adults with unresectable advanced, metastatic, or recurrent NSCLC other than predominantly squamous cell histologyIn combination with erlotinib for first-line treatment of adults with unresectable advanced, metastatic, or recurrent nonsquamous NSCLC with EGFR activating mutationsRenal cell cancer in combination with interferon alfa-2a for first-line treatment of adults with advanced or metastatic disease.Ovarian, fallopian tube, or primary peritoneal cancer:In combination with carboplatin and paclitaxel for the front-line treatment of adults with advanced diseaseIn combination with carboplatin and gemcitabine or carboplatin and paclitaxel for treatment of adults with first recurrence of platinum-sensitive disease who have not received prior therapy with bevacizumab or other vascular endothelial growth factor (VEGF) inhibitors or VEGF receptor-targeted agentsIn combination with paclitaxel, topotecan, or pegylated liposomal doxorubicin for the treatment of adults with platinum-resistant recurrent disease who received no more than two prior chemotherapy regimens and who have not received prior therapy with bevacizumab or other VEGF inhibitors or VEGF receptor-targeted agentsCarcinoma of the cervix in combination with paclitaxel and cisplatin, or alternatively paclitaxel and topotecan in patients who cannot receive platinum therapy, for the treatment of adults with persistent, recurrent, or metastatic disease.

Avzivi will be available as a 25-mg/mL concentrate for solution for infusion. Its active ingredient, bevacizumab, is a monoclonal antibody that binds to VEGF. By inhibiting VEGF binding to its receptors on endothelial cells, it neutralizes VEGF’s biologic activity. This action leads to tumor vascular regression, normalization of remaining tumor vasculature, and inhibition of new tumor vasculature formation, ultimately inhibiting tumor growth.

Generics

The CHMP has also given a positive recommendation for five generic medicines for cancer therapy.

Apexelsin (paclitaxel) is for the treatment of metastatic breast cancer, metastatic adenocarcinoma of the pancreas, and NSCLC.

It is a generic version of Abraxane, an albumin-bound paclitaxel nanoparticle, authorized in the European Union since 2008. Studies confirm the quality of Apexelsin, and a bioequivalence study was not required due to its rapid nanoparticle dissociation on intravenous administration and the qualitative and quantitative similarity to the reference product.

Apexelsin monotherapy treats metastatic breast cancer in adults who did not respond to first-line treatment and can’t have standard anthracycline therapy. When combined with gemcitabine, it is indicated for first-line treatment of adults with metastatic pancreatic adenocarcinoma. In addition, alongside carboplatin, Apexelsin is prescribed for first-line treatment of NSCLC in adults ineligible for potentially curative surgery or radiation therapy.

Apexelsin will be available as a 5-mg/mL powder for dispersion for infusion. Its active ingredient, paclitaxel, is a taxane antineoplastic agent. It works by disrupting microtubule growth, leading to cell division inhibition and apoptosis induction. It also affects noncancer cells, potentially causing side effects.

The panel also endorsed Pomalidomide Accord (pomalidomide), Pomalidomide Krka (pomalidomide), and Pomalidomide Zentiva (pomalidomide) for treating multiple myeloma. These will be available in 1-, 2-, 3-, and 4-mg hard capsules. The active substance pomalidomide, an immunomodulator, acts through cytokine modulation, T-cell proliferation induction, inhibition of multiple myeloma cell proliferation, and angiogenesis inhibition.

As generics of Imnovid, authorized in the European Union since 2013, these drugs demonstrated satisfactory quality and bioequivalence to the reference product (Imnovid).

Dasatinib (Accord Healthcare) was also recommended for approval for the treatment of chronic myelogenous leukemia.

>>> Read full article>>>
Copyright for syndicated content belongs to the linked Source : Medscape – https://www.medscape.com/viewarticle/ema-panel-nods-seven-new-cancer-drugs-2024a1000a9x

Tags: healthPanelSeven
Previous Post

Severe Hypoglycemia in Diabetes Drug Approved in Europe

Next Post

Europe Drops UK ‘Mad Cow’ Blood Ban

New center coming to Mizzou will focus on energy research and technology – Columbia Missourian

Mizzou Launches Innovative New Center Dedicated to Energy Research and Technology

June 30, 2025
Atlanta Dream Dealt Concerning Loss During Liberty Game – Yahoo Sports

Atlanta Dream Faces Crushing Defeat in Thrilling Liberty Clash

June 30, 2025
More than 1,800 National Science Foundation workers abruptly kicked out of agency headquarters – Space

Over 1,800 National Science Foundation Employees Suddenly Evicted from Agency Headquarters

June 30, 2025
Scientists Retrace 30,000-Year-Old Sea Voyage, in a Hollowed-Out Log – The New York Times

Scientists Successfully Recreate Epic 30,000-Year-Old Sea Voyage in a Hollowed-Out Log

June 30, 2025
Tom Brady Ditches Sneakers Lifestyle For Jeff Bezos & Lauren Sánchez’s Wedding – Yahoo

Tom Brady Swaps Sneakers Lifestyle for Glamorous Jeff Bezos and Lauren Sánchez Wedding Celebration

June 30, 2025
Chivu Confirms France Star Fit For Inter Milan Vs Fluminense Club World Cup Clash – Yahoo Sports

Chivu Confirms France Star Ready for Inter Milan’s Club World Cup Showdown Against Fluminense

June 30, 2025
Trump’s tariffs damage the US economy more if they drive investors away from American assets – Peterson Institute for International Economics

How Trump’s Tariffs Could Backfire by Driving Investors Away from American Assets

June 30, 2025
Surprising New Study Links Daytime Napping to Hidden Health Risks – Prevention

Surprising New Research Uncovers Hidden Health Risks of Daytime Napping

June 30, 2025
The 1975’s Matty Healy Says ‘We Don’t Need More Politics’ at Glastonbury – Variety

The 1975’s Matty Healy Declares “We Don’t Need More Politics” at Glastonbury

June 30, 2025
Mirrors in space and underwater curtains: can technology buy us enough time to save the Arctic ice caps? – The Guardian

Can Technology Like Space Mirrors and Underwater Curtains Buy Us Time to Save the Arctic Ice Caps?

June 29, 2025

Categories

Archives

June 2025
MTWTFSS
 1
2345678
9101112131415
16171819202122
23242526272829
30 
« May    
Earth-News.info

The Earth News is an independent English-language daily published Website from all around the World News

Browse by Category

  • Business (20,132)
  • Ecology (700)
  • Economy (724)
  • Entertainment (21,613)
  • General (15,630)
  • Health (9,763)
  • Lifestyle (729)
  • News (22,149)
  • People (725)
  • Politics (730)
  • Science (15,941)
  • Sports (21,221)
  • Technology (15,709)
  • World (704)

Recent News

New center coming to Mizzou will focus on energy research and technology – Columbia Missourian

Mizzou Launches Innovative New Center Dedicated to Energy Research and Technology

June 30, 2025
Atlanta Dream Dealt Concerning Loss During Liberty Game – Yahoo Sports

Atlanta Dream Faces Crushing Defeat in Thrilling Liberty Clash

June 30, 2025
  • About
  • Advertise
  • Privacy & Policy
  • Contact

© 2023 earth-news.info

No Result
View All Result

© 2023 earth-news.info

No Result
View All Result

© 2023 earth-news.info

Go to mobile version